0001127602-15-005582.txt : 20150211 0001127602-15-005582.hdr.sgml : 20150211 20150211200746 ACCESSION NUMBER: 0001127602-15-005582 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150210 FILED AS OF DATE: 20150211 DATE AS OF CHANGE: 20150211 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp CENTRAL INDEX KEY: 0001082554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521984749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 MAIL ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 FORMER COMPANY: FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP DATE OF NAME CHANGE: 19990324 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ZACCARDELLI DAVID CENTRAL INDEX KEY: 0001627642 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26301 FILM NUMBER: 15601315 MAIL ADDRESS: STREET 1: 55 TW ALEXANDER DRIVE STREET 2: PO BOX 14186 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2015-02-10 0001082554 UNITED THERAPEUTICS Corp UTHR 0001627642 ZACCARDELLI DAVID C/O UNITED THERAPEUTICS CORP. 1040 SPRING STREET SILVER SPRING MD 20910 1 EVP & Chief Operating Officer Common Stock 2015-02-10 4 M 0 4000 50.09 A 5153 D Common Stock 2015-02-10 4 S 0 4000 146.68 D 1153 D Share Tracking Award 50.09 2015-02-10 4 M 0 4000 0 D 2010-09-15 2019-09-15 Common Stock 4000 5458 D Exercise of a cash-settled share tracking award pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Exercise price and number of shares/awards has been adjusted to reflect the issuer's two-for-one stock split on September 22, 2009. /s/ John S. Hess, Jr. under Power of Attorney 2015-02-11